about
High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational studyVenous thromboembolism in chronic kidney disease: epidemiology, the role of proteinuria, CKD severity and therapeutics.Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.Is low serum albumin level a significant predictor for the development of heparin-induced thrombocytopenia-thrombosis?Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapyC-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohortChronic kidney disease and venous thromboembolism: epidemiology and mechanisms.Cardiovascular risk associated with interactions among polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systemsReference data for the Ruff Figural Fluency Test stratified by age and educational level.Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.The association of APOE genotype with cognitive function in persons aged 35 years or older.Chronic kidney disease and venous thromboembolism: a prospective study.The association of albuminuria with tubular reabsorption of uric acid: results from a general population cohortInfluence of age and measure of eGFR on the association between renal function and cardiovascular events.Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study.Predictors of progression in albuminuria in the general population: results from the PREVEND cohort.Association of cognitive function with albuminuria and eGFR in the general population.The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older.High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study.Longitudinal study of performance on the Ruff Figural Fluency Test in persons aged 35 years or olderFamily history of myocardial infarction is a risk factor for venous thromboembolism among whites but not among blacks.Influence of urine creatinine on the relationship between the albumin-to-creatinine ratio and cardiovascular events.Agreement between Computerized and Human Assessment of Performance on the Ruff Figural Fluency TestInflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohortPulmonary embolism in patients with CKD and ESRDManaging cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials.Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohortsHypertension associated with venous thromboembolism in patients with newly diagnosed lung cancer.Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality.Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis.Race, ABO blood group, and venous thromboembolism risk: not black and white.Coronary atherosclerosis burden is not advanced in patients with β-thalassemia despite premature extracardiac atherosclerosis: a coronary artery calcium score and carotid intima-media thickness study.Socioeconomic measures and CKD in the United States and The NetherlandsInhibition of renin angiotensin axis may be associated with reduced risk of developing venous thromboembolism in patients with atherosclerotic disease.Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.Glycemia (hemoglobin A1c) and incident venous thromboembolism in the Atherosclerosis Risk in Communities cohort study.Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update.Renal issues in HIV infection.Recent findings on the effects of marine-derived n-3 polyunsaturated fatty acids on urinary albumin excretion and renal function.Venous thromboembolism in pediatric nephrotic syndrome.
P2860
Q28474831-D48889F3-6FEB-471E-B67C-FDACCF8D3601Q30244606-B6B0154D-6B02-442E-B576-45E9DFA8CD52Q31141767-FC95E4CF-7FFC-4807-9240-10462FB3A0C0Q33440099-976CF40E-4CE2-4CF3-AD5F-66B10CDCA1D5Q33577831-7464A947-87BF-42FF-8777-EC031F04B4A1Q33605095-6EFA1BF2-1B63-4788-889D-E048A3A66EFFQ33610908-E42A11C3-3A4E-4037-A6E4-B600F4786FCDQ33697706-405A0096-861E-4F09-BD7C-8C7CFD8B3C3AQ33828539-F970D0D9-A8DA-4782-A07D-1D7DC68423B4Q33990767-A69B283D-0F63-4056-97ED-CB45FB96450DQ34081529-91BF94B4-6B83-4EFA-BA9C-1B968BFF605EQ34169626-C2CA1710-D474-4E57-80B7-17571417FE78Q34297101-DDEEB6A2-4924-474B-BF11-86AD6106178FQ34405328-FC02D531-BA6A-4FFD-BF5F-BAD7E120F4F5Q34410222-0447EA7D-AD3B-4CD8-906E-D9B980D0D970Q34749180-92EB30CC-56A1-43D0-89E4-47FC1EC501B4Q35030627-A422E9C2-F93C-4110-B596-19FB63C0A24BQ35075501-BE1768C2-C0E0-4134-8212-42FC84CFA46BQ35143506-A5F3BA08-F0AB-42FF-A4D5-7A7E7AC25E64Q35208218-F8696F3A-1399-4471-AF2F-2B2CE3A53424Q35781270-663D4DB4-A3F5-4A38-8AB7-776CB032A2F9Q35860711-E171699B-7649-46C0-B070-757A55ECD50BQ36142377-87D9BA64-A5CA-49A4-9CFE-BE545D7B18EDQ36277129-BEA96523-60E2-4D21-8FA1-4AABEE72D8D0Q36294323-5994D66B-7AF3-4D69-B0B0-64F718C54C92Q36443751-AAFB51F9-1D59-4479-8E23-9ED95EFF658FQ36460573-E4698F3A-85E3-4031-990A-19B432F7922DQ36500459-7A107B87-67FD-4623-A14A-A422E07D7812Q36522598-9A6D6549-49A3-4229-A686-4790E6D4D8F5Q36578193-7CAD6FF7-D668-4082-8E08-55C3C409BFE0Q36594002-3078F9EE-2A36-4FE0-8CA8-E0046E1EAB86Q36863932-3A215A97-887B-43A2-BFE0-312E71038397Q37212395-5631C168-CE3A-497D-9B62-B3FBC10D3D55Q37539202-27A996E4-F12C-44D6-9A09-B908234D091DQ37609437-8D69E731-DA16-41A4-9A64-6728FD1F1A8BQ37693298-C6283074-2419-4DE5-A99C-E403B46B56D3Q37860968-AB7215A7-D19F-49B7-BFD9-A95F55664A79Q37885232-D6654E1C-532E-4F6B-82EA-2A6A609180BCQ38034098-2A7FB40F-E824-4538-8602-372C7431F469Q38118114-6BD73F2C-892F-454B-861B-309F81EE0A1E
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Microalbuminuria and risk of venous thromboembolism
@ast
Microalbuminuria and risk of venous thromboembolism
@en
Microalbuminuria and risk of venous thromboembolism
@nl
type
label
Microalbuminuria and risk of venous thromboembolism
@ast
Microalbuminuria and risk of venous thromboembolism
@en
Microalbuminuria and risk of venous thromboembolism
@nl
prefLabel
Microalbuminuria and risk of venous thromboembolism
@ast
Microalbuminuria and risk of venous thromboembolism
@en
Microalbuminuria and risk of venous thromboembolism
@nl
P2093
P3181
P356
P1476
Microalbuminuria and risk of venous thromboembolism
@en
P2093
Abigail G Matthews
Bakhtawar K Mahmoodi
Hans L Hillege
Jan van der Meer
Nic J G M Veeger
Ron T Gansevoort
P304
P3181
P356
10.1001/JAMA.2009.565
P407
P50
P577
2009-05-06T00:00:00Z